Jeremy Ramdial

25PUBLICATIONS
86CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRespiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jul 24, 2026
Prognostic impact of monosomy 13 and deletion of 13q in multiple myeloma patients undergoing upfront autologous transplantation.

|Jul 06, 2026
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma.

|May 06, 2026
Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy.

|Mar 10, 2026
Reduced relapse in high risk acute myeloid leukemia and myelodysplastic neoplasms with permissive HLA-DPB1 mismatches and post-transplant cyclophosphamide.

Portia Smallbone, Kai Cao, Rima M Saliba

|Jan 12, 2026
Clinical trial access after CAR T-cell therapy failure in relapsed/refractory large B-cell lymphoma.

Kunhwa Kim, Rahul Shah, Amy Ayers

|Dec 05, 2025
Results of delayed or salvage autologous hematopoietic stem cell transplantation for multiple myeloma.

Oren Pasvolsky, Curtis Marcoux, Denái R Milton

Pageof 5

Frequent Collaborators

15 joint publications

Yago Nieto

13 joint publications

Muzaffar Qazilbash

10 joint publications

Yosra M Aljawai

9 joint publications

Uday R Popat